This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Hanmi Pharm. Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations of Chong Yoon Lim in Respiratory Disease Treatment.
Introduction
Chong Yoon Lim is a notable inventor based in Hwaseong-si, Gyeonggi-do, South Korea. He has made significant contributions to the field of medicine, particularly in the treatment of respiratory infectious diseases. His innovative approach has led to the development of a unique patent that addresses critical health issues.
Latest Patents
Chong Yoon Lim holds a patent titled "Use of Trigonal Agonist Having Activities to All of Glucagon, GLP-1, and GIP Receptors in Treatment of Sequelae Following Respiratory Infectious Diseases." This patent highlights his commitment to advancing medical treatments and improving patient outcomes.
Career Highlights
Lim is currently employed at Hanmi Pharmaceutical Co., Ltd., where he continues to work on groundbreaking research and development projects. His expertise and dedication have positioned him as a key figure in the pharmaceutical industry.
Collaborations
Chong Yoon Lim collaborates with talented professionals in his field, including Jung Kuk Kim and Jong Suk Lee. These partnerships enhance the innovative potential of his work and contribute to the advancement of medical science.
Conclusion
Chong Yoon Lim's contributions to the treatment of respiratory diseases through his innovative patent demonstrate his significant impact on the medical field. His work at Hanmi Pharmaceutical Co., Ltd. and collaborations with esteemed colleagues further underscore his dedication to improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile